Not a cure, but able to stabilise it which then will give scientists a new base to work from to improve the technology. But if used to treat other cancer types, according to CHM, it could work. Would be nice to know if any of the trial patients had secondary cancers which became less or even eradicated.
But compared to what's available the data / results are fantastic, best ever. But still not anywhere close enough to what sufferers need. But all great treatments started with small improvements. They mentioned in the webinar that CHM 1101 could be used to treat children as well as the safety data are so good. That alone is a huge market.
GLTA
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial, page-47
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |